STOCK TITAN

Sight Sciences (SGHT) Insider Sale Notice — 19,948 Shares on 10/02/2025

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Sight Sciences, Inc. (SGHT) Form 144 summary: The filing notifies a proposed sale of 19,948 common shares through Fidelity Brokerage Services with an approximate aggregate market value of $65,750.60. The sale is scheduled for 10/02/2025 on NASDAQ and the issuer reports 52,367,359 shares outstanding. The shares were acquired on 09/30/2025 through restricted stock vesting and were recorded as compensation. The filer also disclosed a prior sale of 19,260 shares on 07/02/2025 that generated $78,933.26 in gross proceeds. The notice includes the standard signature representation that the seller is unaware of undisclosed material adverse information.

Positive

  • Acquisition via restricted stock vesting on 09/30/2025 (19,948 shares)
  • Full disclosure of broker and planned sale date for compliance (Fidelity; 10/02/2025)

Negative

  • Insider proposes to sell 19,948 shares (aggregate market value $65,750.60) on 10/02/2025
  • Prior insider sale of 19,260 shares on 07/02/2025 (gross proceeds $78,933.26)

Insights

TL;DR: Insider plans to sell ~19.9k shares after restricted stock vesting; another ~19.3k shares were sold in July.

The filing shows a proposed open-market sale of 19,948 common shares scheduled for 10/02/2025, following a restricted stock vesting on 09/30/2025 that delivered those shares as compensation. The filer previously sold 19,260 shares on 07/02/2025 for $78,933.26. These are explicit, recorded insider transactions rather than purchases or transfers.

Why it matters: Insider sales change immediate share supply and are routinely monitored by investors for timing and size; both the proposed sale and the prior sale are documented with dates and amounts in the filing.

TL;DR: Form 144 documents compliance with Rule 144 for a compensatory restricted stock sale and includes the seller's attestation.

The submission identifies the acquisition as restricted stock vesting and lists the sale broker and planned sale date, fulfilling the Form 144 disclosure elements. The notice includes the seller's signed representation that no undisclosed material adverse information is known, and warns of criminal penalties for misstatements.

This filing is a procedural disclosure required before an intended resale under Rule 144 and records the factual elements needed for compliance.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What shares does the SGHT Form 144 report a proposed sale for?

The filing reports a proposed sale of 19,948 common shares on NASDAQ.

When is the planned sale date and which broker is named?

The sale is scheduled for 10/02/2025 and lists Fidelity Brokerage Services LLC as the broker.

How were the shares being sold acquired?

The shares were acquired on 09/30/2025 through restricted stock vesting and recorded as compensation.

How many shares outstanding does the filing list for the issuer?

The filing lists 52,367,359 shares outstanding.

Has the filer sold shares of the issuer recently?

Yes. The filing discloses a prior sale of 19,260 shares on 07/02/2025 for $78,933.26 in gross proceeds.
Sight Sciences, Inc.

NASDAQ:SGHT

SGHT Rankings

SGHT Latest News

SGHT Latest SEC Filings

SGHT Stock Data

446.24M
41.81M
20.66%
50.37%
1.99%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MENLO PARK